ArticleFrontiers in artificial intelligence2026
A quantum-classical dual-track deep learning network for explainable Parkinson's disease classification.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by the loss of dopaminergic neurons in the substantia nigra, presenting with motor and non-motor symptoms in roughly 2-3% of the global population above age 60. Early detection is difficult because symptoms are subtle and often indistinguishable from normal aging. The MDS-UPDRS rating scale, the current clinical standard, is time-intensive, subjective, and requires experienced clinicians. Most computational approaches are unimodal and do not use image and structured clinical data in combination. Methods: We propose a hybrid quantum-classical dual-track multimodal network that classifies PD patients and healthy controls from hand-drawn spiral and meander patterns. The first track, the Topological Visual-Spatial Feature Encoder Network (TVSFE), uses a ghost module-based CNN with Cross-Dimensional Attention Bottleneck (CDAB) blocks incorporating coordinate attention, squeeze-and-excitation, and triplet attention, followed by a quantum variational circuit with amplitude embedding. The second track, the Variational Quantum Feature Mapping Network (VQFMN), encodes structured clinical and demographic data through RY rotation gates and strongly entangling layers. Outputs from both tracks are concatenated and passed through fully connected layers for classification. Results: On the HandPD test set, the model achieved 97.28% accuracy, 96.60% precision, 96.62% recall, and 96.54% F1-score, outperforming all CNN, transformer, and ML-based baselines compared. Five-fold cross-validation produced a mean accuracy of 96.58%. On the NewHandPD dataset, accuracy, precision, recall, and F1-score were all 95.45%. Discussion: The quantum-classical fusion outperforms both single-modality and fully classical variants. Grad-CAM localizes the spatial image regions driving classification and the perturbation-based sensitivity analysis identifies Root Mean Square (RMS) and age as the most influential structured features. Both together make the model's reasoning traceable at the modality level, which is important for decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.